Talkmed Group Ltd
SGX:5G3
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
SG |
T
|
Talkmed Group Ltd
SGX:5G3
|
530.2m SGD | 16.5 | |
US |
C
|
Cigna Group
XMUN:CGN
|
89.2B EUR | 26.8 | |
US |
Cigna Corp
NYSE:CI
|
96.3B USD | 26.6 | ||
US |
CVS Health Corp
NYSE:CVS
|
72.2B USD | 9.9 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.8B USD | 41 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | -49.8 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
16B USD | 19 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 24.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 24.5 | |
US |
DaVita Inc
NYSE:DVA
|
12.3B USD | 15 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.